The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Blood Cancer Awareness Month is when people from all around the world come together in September to help raise awareness of blood cancers such as AML.
Discover video stories from patients, caregivers, and healthcare professionals as they #TalkAML and share their experiences of mental health and wellbeing support from all over the world.
Diagnosing AML involves tests which look at cells in the blood and bone marrow. Tests include bone marrow biopsies, blood tests, and chromosomal and genetic studies.
There are a number of factors that can influence a patient's prognosis, including genetic and chromosomal abnormalities, age and overall health, a history of blood disorders or previous cancers, and response to chemotherapy.
The aim of treatment is to restore a balance of healthy blood cells and control abnormal leukemia cells, and will vary depending on the type of AML patient has. Treatment options include chemotherapy with anticancer or drugs targeted to particular leukemia cells, stem cell transplantation, or opportunities to take part in clinical trials.
Once there are no detectable leukemia cells in the blood or bone marrow, a patient is said to be in 'remission'. There may still be low levels of leukemia cells so patients will be closely observed and attend regular follow-ups.
Sometimes AML can return in patients who have been in remission, several months or even years later. Regular follow-ups are important so that relapse is detected early and treatment options can be discussed.
Touch / hover to interact
Our campaign aims to empower you by encouraging dialogue in AML – #TalkAML – around the importance of provision and access to mental health and wellbeing support for patients, carers, and HCPs. Cancer can lead to an array of feelings and experiences; and you are more than a patient, more than your treatment regime.
To show your support for #TalkAML 2023:
This will aid in empowering you to #TalkAML with your doctor, nurse, psychologist, counsellor, family, friends, and charities, etc. You, or anyone else, don’t need to go through this alone. We want to help you receive the mental health and wellbeing support you deserve while experiencing AML and beyond.
If you aren’t on social media and would like to get involved offline, all materials can be downloaded, edited, translated, and sent to us at SES_KnowAML@scientificeducationsupport.com. Our briefing guide also has all the information you need on how to get involved.
You can also find our Blood Cancer Awareness Month downloadable and translatable resources on our resources page.
We’d really appreciate your feedback to help us continuously improve our campaigns. Before we start our campaign, please let us know a little about your current understanding of the access to and benefits of mental health and wellbeing support for people with AML and caregivers. Complete the survey here.
Find our Blood Cancer Awareness Month 2023 press release here.